9E84 image
Deposition Date 2024-11-05
Release Date 2025-10-01
Last Version Date 2025-12-03
Entry Detail
PDB ID:
9E84
Title:
De Novo Mycobacterium tuberculosis transcription initiation promoter complex with 6-mer RNA and disordered Sigma-A region 4 domain (RNA Polymerase with Sigma-A, CarD, and RbpA)
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA-directed RNA polymerase subunit alpha
Gene (Uniprot):rpoA
Chain IDs:A, B
Chain Length:347
Number of Molecules:2
Biological Source:Mycobacterium tuberculosis
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA-directed RNA polymerase subunit beta
Gene (Uniprot):rpoB
Chain IDs:C
Chain Length:1178
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA-directed RNA polymerase subunit beta'
Gene (Uniprot):rpoC
Chain IDs:D
Chain Length:1333
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA-directed RNA polymerase subunit omega
Gene (Uniprot):rpoZ
Chain IDs:E
Chain Length:110
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:RNA polymerase sigma factor SigA
Gene (Uniprot):sigA
Chain IDs:F
Chain Length:550
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:RNA polymerase-binding protein RbpA
Gene (Uniprot):rbpA
Chain IDs:G (auth: J)
Chain Length:111
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Ubiquitin-like protein SMT3,RNA polymerase-binding transcription factor CarD
Gene (Uniprot):carD, SMT3
Chain IDs:H (auth: M)
Chain Length:285
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (123-MER)
Chain IDs:I (auth: N)
Chain Length:127
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polyribonucleotide
Molecule:RNA (21-mer)
Chain IDs:J (auth: R)
Chain Length:21
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (127-MER)
Chain IDs:K (auth: T)
Chain Length:127
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Structural Insights into De Novo Promoter Escape by Mycobacterium tuberculosis RNA Polymerase.
Nat Commun 16 9990 9990 (2025)
PMID: 41233305 DOI: 10.1038/s41467-025-64941-7

Abstact

Transcription in bacteria is a multi-step process. In the first step, contacts between RNA polymerase and the promoter DNA must be established for transcription initiation to begin, but then these contacts must be broken for the enzyme to transition into the elongation phase. Single-molecule and biochemical observations report that promoter escape is a highly regulated and sometimes rate-limiting step in the transcription cycle; however, the structural mechanisms of promoter escape remain obscure. Promoter escape also serves as the target for the clinically important antibiotic rifampicin, used to treat tuberculosis. Here, we present seven distinct intermediates showing the structural details of M. tuberculosis RNA polymerase initial transcribing complexes and promoter escape, using a de novo cryo-electron microscopy approach. We describe the structural rearrangements that RNA polymerase undergoes to clear the promoter, including those required to release the initiation factor, σ, providing a structural account for decades of biochemical observations. These structures and supporting biochemistry provide a model of promoter escape, a universal step in the transcription cycle, with conformations that may be used to develop Rifampicin alternatives.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback